CBPE Capital

Showing 1 posts of 1 posts found.

Chief executive Peter George image

Clinigen buys Idis for £225 million

April 24, 2015
Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed

UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …

The Gateway to Local Adoption Series

Latest content